
Release date: 2026-02-27 17:43:00 Article From: Lucius Laos Recommended: 9
During treatment with sotorasib, consuming large amounts of greasy food is generally not recommended. However, small or occasional intake is usually acceptable, depending on individual health conditions and the advice of your doctor.
May Increase Digestive Burden: As a targeted therapy, sotorasib can potentially cause gastrointestinal reactions such as nausea and diarrhea. Greasy foods may exacerbate these discomforts.
May Affect Drug Absorption: A high-fat diet could potentially slow down the rate of drug absorption. However, current research has not definitively confirmed a direct impact on the effectiveness of sotorasib itself.
Focus on a Light, Easily Digestible Diet: Prioritize a nutritionally balanced diet with options like lean protein, vegetables, and whole grains to reduce the burden on your gastrointestinal system.
Try Small Amounts: If you tolerate greasy foods well, you might try a small amount and observe your body's reaction. Discontinue immediately if any discomfort arises.
Avoid Long-Term High-Fat Diet: Chronic excessive intake of fat may increase the metabolic stress on the liver. Since sotorasib is metabolized by the liver, this could potentially affect how the drug is cleared from the body.
Presence of Other Medical Conditions: If you have conditions such as gallbladder disease, pancreatitis, or hyperlipidemia (high blood fat), you should strictly limit your intake of greasy foods.
Pronounced Reactions After Medication: If you frequently experience symptoms like vomiting or abdominal pain after taking the medication, you need to adjust your diet and consult your doctor promptly.
Lucius Pharmaceuticals Sotorasib is a prescription medication. It is essential to strictly follow your doctor's guidance during treatment, including recommendations on diet, dosage, and monitoring for adverse reactions. It is advisable to consult your doctor or a registered dietitian before starting the medication to develop an individualized dietary plan, ensuring the treatment is both safe and effective.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:1382025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3882024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:1372025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:1472025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:1382025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:1602025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:1462025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:1442025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: